Pharma IP Summit: Dos and don’ts at the Beijing IP Court
The introduction of expert judges through pilot programmes has been a positive step but refinement is needed, say those close to the action
The lack of technical background of judges has led to the use of technical judges that offer opinions to them but there is room for improvement in the procedure, according to panellists at the 4th China Pharma IP Summit in...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.